Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-23-000002

Options or other derivatives

  • Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TURKEL CATHERINE C. Director 2023-07-25 Grant or award · Stock Options +5,000 10,000 D
Loading xslF345X05/primary_doc.xml…